<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34245450</PMID><DateRevised><Year>2021</Year><Month>07</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2193-8229</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Infectious diseases and therapy</Title><ISOAbbreviation>Infect Dis Ther</ISOAbbreviation></Journal><ArticleTitle>Refining "Long-COVID" by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection.</ArticleTitle><Pagination><StartPage>1747</StartPage><EndPage>1763</EndPage><MedlinePgn>1747-1763</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40121-021-00484-w</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">COVID-19 long-haulers, also decribed as having "long-COVID" or post-acute COVID-19 syndrome, represent 10% of COVID-19 patients and remain understudied.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this prospective study, we recruited 30 consecutive patients seeking medical help for persistent symptoms (&gt;&#x2009;30&#xa0;days) attributed to COVID-19. All reported a viral illness compatible with COVID-19. The patients underwent a multi-modal evaluation, including clinical, psychologic, virologic and specific immunologic assays and were followed longitudinally. A group of 17 convalescent COVID-19 individuals without persistent symptoms were included as a comparison group.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The median age was 40 [interquartile range: 35-54] years and 18 (60%) were female. At a median time of 152 [102-164] days after symptom onset, fever, cough and dyspnea were less frequently reported compared with the initial presentation, but paresthesia and burning pain emerged in 18 (60%) and 13 (43%) patients, respectively. The clinical examination was unremarkable in all patients, although the median fatigue and pain visual analog scales were 7 [5-8] and 5 [2-6], respectively. Extensive biologic studies were unremarkable, and multiplex cytokines and ultra-sensitive interferon-&#x3b1;2 measurements were similar between long-haulers and convalescent COVID-19 individuals without persistent symptoms. Using SARS-CoV-2 serology and IFN-&#x3b3; ELISPOT, we found evidence of a previous SARS-CoV-2 infection in 50% (15/30) of patients, with evidence of a lack of immune response, or a waning immune response, in two patients. Finally, psychiatric evaluation showed that 11 (36.7%), 13 (43.3%) and 9 (30%) patients had a positive screening for anxiety, depression and post-traumatic stress disorder, respectively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Half of patients seeking medical help for post-acute COVID-19 syndrome lack SARS-CoV-2 immunity. The presence of SARS-CoV-2 immunity, or not, had no consequence on the clinical or biologic characteristics of post-acute COVID-19 syndrome patients, all of whom reported severe fatigue, altered quality of life and psychologic distress.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Scherlinger</LastName><ForeName>Marc</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9453-5895</Identifier><AffiliationInfo><Affiliation>Rheumatology Department, Centre Hospitalier Universitaire de Strasbourg, 1 Avenue Moli&#xe8;re, 67098, Strasbourg, France. marc.scherlinger@chru-strasbourg.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre National de R&#xe9;f&#xe9;rence Des Maladies Auto-Immunes Et Syst&#xe9;miques Rares, Est/Sud-Ouest (RESO), Service de Rhumatologie du CHU de Strasbourg, 1 Avenue Moli&#xe8;re, 67200, Strasbourg Cedex, France. marc.scherlinger@chru-strasbourg.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Felten</LastName><ForeName>Renaud</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Centre Hospitalier Universitaire de Strasbourg, 1 Avenue Moli&#xe8;re, 67098, Strasbourg, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre National de R&#xe9;f&#xe9;rence Des Maladies Auto-Immunes Et Syst&#xe9;miques Rares, Est/Sud-Ouest (RESO), Service de Rhumatologie du CHU de Strasbourg, 1 Avenue Moli&#xe8;re, 67200, Strasbourg Cedex, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallais</LastName><ForeName>Floriane</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Virology Diagnostic Laboratory, Centre Hospitalier Universitaire de Strasbourg, 3 Rue Koeberl&#xe9;, 67000, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nazon</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Virology Diagnostic Laboratory, Centre Hospitalier Universitaire de Strasbourg, 3 Rue Koeberl&#xe9;, 67000, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chatelus</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Centre Hospitalier Universitaire de Strasbourg, 1 Avenue Moli&#xe8;re, 67098, Strasbourg, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre National de R&#xe9;f&#xe9;rence Des Maladies Auto-Immunes Et Syst&#xe9;miques Rares, Est/Sud-Ouest (RESO), Service de Rhumatologie du CHU de Strasbourg, 1 Avenue Moli&#xe8;re, 67200, Strasbourg Cedex, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pijnenburg</LastName><ForeName>Luc</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Centre Hospitalier Universitaire de Strasbourg, 1 Avenue Moli&#xe8;re, 67098, Strasbourg, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre National de R&#xe9;f&#xe9;rence Des Maladies Auto-Immunes Et Syst&#xe9;miques Rares, Est/Sud-Ouest (RESO), Service de Rhumatologie du CHU de Strasbourg, 1 Avenue Moli&#xe8;re, 67200, Strasbourg Cedex, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mengin</LastName><ForeName>Amaury</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre Hospitalier Universitaire de Strasbourg, 1 Avenue Moli&#xe8;re, 67098, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gras</LastName><ForeName>Adrien</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre Hospitalier Universitaire de Strasbourg, 1 Avenue Moli&#xe8;re, 67098, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vidailhet</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centre Hospitalier Universitaire de Strasbourg, 1 Avenue Moli&#xe8;re, 67098, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arnould-Michel</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Centre Hospitalier Universitaire de Strasbourg, 1 Avenue Moli&#xe8;re, 67098, Strasbourg, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre National de R&#xe9;f&#xe9;rence Des Maladies Auto-Immunes Et Syst&#xe9;miques Rares, Est/Sud-Ouest (RESO), Service de Rhumatologie du CHU de Strasbourg, 1 Avenue Moli&#xe8;re, 67200, Strasbourg Cedex, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bibi-Triki</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratoire D'ImmunoRhumatologie Mol&#xe9;culaire, Institut National de La Sant&#xe9; Et de La Recherche M&#xe9;dicale (INSERM) UMR_S 1109, Institut Th&#xe9;matique Interdisciplinaire (ITI) de M&#xe9;decine de Pr&#xe9;cision de Strasbourg, Transplantex NG, Facult&#xe9; de M&#xe9;decine, F&#xe9;d&#xe9;ration Hospitalo-Universitaire OMICARE, F&#xe9;d&#xe9;ration de M&#xe9;decine Translationnelle de Strasbourg (FMTS), Universit&#xe9; de Strasbourg, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carapito</LastName><ForeName>Rapha&#xeb;l</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Laboratoire D'ImmunoRhumatologie Mol&#xe9;culaire, Institut National de La Sant&#xe9; Et de La Recherche M&#xe9;dicale (INSERM) UMR_S 1109, Institut Th&#xe9;matique Interdisciplinaire (ITI) de M&#xe9;decine de Pr&#xe9;cision de Strasbourg, Transplantex NG, Facult&#xe9; de M&#xe9;decine, F&#xe9;d&#xe9;ration Hospitalo-Universitaire OMICARE, F&#xe9;d&#xe9;ration de M&#xe9;decine Translationnelle de Strasbourg (FMTS), Universit&#xe9; de Strasbourg, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trouillet-Assant</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Reference Centre for Rare Rheumatic and AutoImmune Diseases in childrEn RAISE, Hospices Civils de Lyon, CIRI, Centre International de Recherche en Infectiologie, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, 69007, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perret</LastName><ForeName>Magali</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Reference Centre for Rare Rheumatic and AutoImmune Diseases in childrEn RAISE, Hospices Civils de Lyon, CIRI, Centre International de Recherche en Infectiologie, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, 69007, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belot</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Reference Centre for Rare Rheumatic and AutoImmune Diseases in childrEn RAISE, Hospices Civils de Lyon, CIRI, Centre International de Recherche en Infectiologie, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, 69007, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahram</LastName><ForeName>Seiamak</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratoire D'ImmunoRhumatologie Mol&#xe9;culaire, Institut National de La Sant&#xe9; Et de La Recherche M&#xe9;dicale (INSERM) UMR_S 1109, Institut Th&#xe9;matique Interdisciplinaire (ITI) de M&#xe9;decine de Pr&#xe9;cision de Strasbourg, Transplantex NG, Facult&#xe9; de M&#xe9;decine, F&#xe9;d&#xe9;ration Hospitalo-Universitaire OMICARE, F&#xe9;d&#xe9;ration de M&#xe9;decine Translationnelle de Strasbourg (FMTS), Universit&#xe9; de Strasbourg, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arnaud</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Centre Hospitalier Universitaire de Strasbourg, 1 Avenue Moli&#xe8;re, 67098, Strasbourg, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre National de R&#xe9;f&#xe9;rence Des Maladies Auto-Immunes Et Syst&#xe9;miques Rares, Est/Sud-Ouest (RESO), Service de Rhumatologie du CHU de Strasbourg, 1 Avenue Moli&#xe8;re, 67200, Strasbourg Cedex, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratoire D'ImmunoRhumatologie Mol&#xe9;culaire, Institut National de La Sant&#xe9; Et de La Recherche M&#xe9;dicale (INSERM) UMR_S 1109, Institut Th&#xe9;matique Interdisciplinaire (ITI) de M&#xe9;decine de Pr&#xe9;cision de Strasbourg, Transplantex NG, Facult&#xe9; de M&#xe9;decine, F&#xe9;d&#xe9;ration Hospitalo-Universitaire OMICARE, F&#xe9;d&#xe9;ration de M&#xe9;decine Translationnelle de Strasbourg (FMTS), Universit&#xe9; de Strasbourg, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gottenberg</LastName><ForeName>Jacques-Eric</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Centre Hospitalier Universitaire de Strasbourg, 1 Avenue Moli&#xe8;re, 67098, Strasbourg, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre National de R&#xe9;f&#xe9;rence Des Maladies Auto-Immunes Et Syst&#xe9;miques Rares, Est/Sud-Ouest (RESO), Service de Rhumatologie du CHU de Strasbourg, 1 Avenue Moli&#xe8;re, 67200, Strasbourg Cedex, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IBMC, UPR3572, CNRS, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fafi-Kremer</LastName><ForeName>Samira</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Virology Diagnostic Laboratory, Centre Hospitalier Universitaire de Strasbourg, 3 Rue Koeberl&#xe9;, 67000, Strasbourg, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratoire D'ImmunoRhumatologie Mol&#xe9;culaire, Institut National de La Sant&#xe9; Et de La Recherche M&#xe9;dicale (INSERM) UMR_S 1109, Institut Th&#xe9;matique Interdisciplinaire (ITI) de M&#xe9;decine de Pr&#xe9;cision de Strasbourg, Transplantex NG, Facult&#xe9; de M&#xe9;decine, F&#xe9;d&#xe9;ration Hospitalo-Universitaire OMICARE, F&#xe9;d&#xe9;ration de M&#xe9;decine Translationnelle de Strasbourg (FMTS), Universit&#xe9; de Strasbourg, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sibilia</LastName><ForeName>Jean</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Centre Hospitalier Universitaire de Strasbourg, 1 Avenue Moli&#xe8;re, 67098, Strasbourg, France. jean.sibilia@chru-strasbourg.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre National de R&#xe9;f&#xe9;rence Des Maladies Auto-Immunes Et Syst&#xe9;miques Rares, Est/Sud-Ouest (RESO), Service de Rhumatologie du CHU de Strasbourg, 1 Avenue Moli&#xe8;re, 67200, Strasbourg Cedex, France. jean.sibilia@chru-strasbourg.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratoire D'ImmunoRhumatologie Mol&#xe9;culaire, Institut National de La Sant&#xe9; Et de La Recherche M&#xe9;dicale (INSERM) UMR_S 1109, Institut Th&#xe9;matique Interdisciplinaire (ITI) de M&#xe9;decine de Pr&#xe9;cision de Strasbourg, Transplantex NG, Facult&#xe9; de M&#xe9;decine, F&#xe9;d&#xe9;ration Hospitalo-Universitaire OMICARE, F&#xe9;d&#xe9;ration de M&#xe9;decine Translationnelle de Strasbourg (FMTS), Universit&#xe9; de Strasbourg, Strasbourg, France. jean.sibilia@chru-strasbourg.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Infect Dis Ther</MedlineTA><NlmUniqueID>101634499</NlmUniqueID><ISSNLinking>2193-6382</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Disability</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Pain</Keyword><Keyword MajorTopicYN="N">Patient perspective</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>10</Day><Hour>12</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34245450</ArticleId><ArticleId IdType="pmc">PMC8270770</ArticleId><ArticleId IdType="doi">10.1007/s40121-021-00484-w</ArticleId><ArticleId IdType="pii">10.1007/s40121-021-00484-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, for the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Living with Covid19 [Internet]. National Institute for Health Research; 2020 Oct [cited 2020 Nov 13]. Available from: https://evidence.nihr.ac.uk/themedreview/living-with-covid19/</Citation></Reference><Reference><Citation>Covid Long Haulers Describe the Devastating Aftereffects of the Disease. Bloomberg.com [Internet]. 2020 Nov 9 [cited 2020 Dec 5]; Available from: https://www.bloomberg.com/news/features/2020-11-09/coronavirus-long-haulers-tell-us-their-symptoms-and-the-aftereffects-of-disease</Citation></Reference><Reference><Citation>Long Covid: &#x2018;Is this now me forever?&#x2019; [Internet]. the Guardian. 2020 [cited 2020 Dec 5]. Available from: http://www.theguardian.com/world/2020/nov/29/eleanor-morgan-is-still-struggling-with-long-covid-months-after-catching-the-virus</Citation></Reference><Reference><Citation>Martinez MW, Tucker AM, Bloom OJ, Green G, DiFiori JP, Solomon G, et al. Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening. JAMA Cardiol [Internet]. 2021 Mar 4 [cited 2021 Jun 1]; Available from: https://jamanetwork.com/journals/jamacardiology/fullarticle/2777308</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7934073</ArticleId><ArticleId IdType="pubmed">33662103</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med [Internet]. 2021 May 5 [cited 2021 Jun 1];0(0). Available from: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00174-0/abstract</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Pero A, Ng S, Cai D. COVID-19: a perspective from clinical neurology and neuroscience. Neuroscientist. 2020;26(5&#x2013;6):387&#x2013;391. doi: 10.1177/1073858420946749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858420946749</ArticleId><ArticleId IdType="pubmed">32713251</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O&#x2019;Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. 2020;174(4):576&#x2013;578. doi: 10.7326/M20-5661.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet. 2021;397(10270):220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Casals M, Brito-Zer&#xf3;n P, Mariette X. Systemic and organ-specific immune-related manifestations of COVID-19. Nat Rev Rheumatol. 2021;17(6):315&#x2013;332. doi: 10.1038/s41584-021-00608-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00608-z</ArticleId><ArticleId IdType="pmc">PMC8072739</ArticleId><ArticleId IdType="pubmed">33903743</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence of long COVID symptoms and COVID-19 complications - Office for National Statistics [Internet]. [cited 2020 Dec 16]. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/datasets/prevalenceoflongcovidsymptomsandcovid19complications</Citation></Reference><Reference><Citation>Yelin D, Wirtheim E, Vetter P, Kalil AC, Bruchfeld J, Runold M, et al. Long-term consequences of COVID-19: research needs. Lancet Infect Dis. 2020;20(10):1115&#x2013;1117. doi: 10.1016/S1473-3099(20)30701-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30701-5</ArticleId><ArticleId IdType="pmc">PMC7462626</ArticleId><ArticleId IdType="pubmed">32888409</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV. Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metab Syndr Clin Res Rev. 2021;15(1):145&#x2013;146. doi: 10.1016/j.dsx.2020.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.12.025</ArticleId><ArticleId IdType="pmc">PMC7737559</ArticleId><ArticleId IdType="pubmed">33341598</ArticleId></ArticleIdList></Reference><Reference><Citation>Salje H, Kiem CT, Lefrancq N, Courtejoie N, Bosetti P, Paireau J, et al. Estimating the burden of SARS-CoV-2 in France. Science. 2020;369(6500):208&#x2013;211. doi: 10.1126/science.abc3517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc3517</ArticleId><ArticleId IdType="pmc">PMC7223792</ArticleId><ArticleId IdType="pubmed">32404476</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruccu G, Sommer C, Anand P, Attal N, Baron R, Garcia-Larrea L, et al. EFNS guidelines on neuropathic pain assessment: revised 2009: Neuropathic pain assessment. Eur J Neurol. 2010;17(8):1010&#x2013;1018. doi: 10.1111/j.1468-1331.2010.02969.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2010.02969.x</ArticleId><ArticleId IdType="pubmed">20298428</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrot S, Bouhassira D, Fermanian J. Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST): Pain. 2010;150(2):250&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20488620</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodero MP, Decalf J, Bondet V, Hunt D, Rice GI, Werneke S, et al. Detection of interferon alpha protein reveals differential levels and cellular sources in disease. J Exp Med. 2017;214(5):1547&#x2013;1555. doi: 10.1084/jem.20161451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20161451</ArticleId><ArticleId IdType="pmc">PMC5413335</ArticleId><ArticleId IdType="pubmed">28420733</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberge P. A psychometric evaluation of the French Canadian version of the Hospital Anxiety and Depression Scale in a large primary care population. J Affect Disord. 2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23218249</ArticleId></ArticleIdList></Reference><Reference><Citation>Bovin MJ, Marx BP, Weathers FW, Gallagher MW, Rodriguez P, Schnurr PP, et al. Psychometric properties of the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (PCL-5) in veterans. Psychol Assess. 2016;28(11):1379&#x2013;1391. doi: 10.1037/pas0000254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/pas0000254</ArticleId><ArticleId IdType="pubmed">26653052</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, Taylor S, Rayner C, Husain L, et al. Persistent symptoms after Covid-19: qualitative study of 114 &#x201c;long Covid&#x201d; patients and draft quality principles for services. BMC Health Serv Res. 2020;20(1):1144. doi: 10.1186/s12913-020-06001-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarzkopf S, Krawczyk A, Knop D, Klump H, Heinold A, Heinemann FM, et al. Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2&#x2013;Specific IgG - Volume 27, Number 1&#x2014;January 2021 - Emerging Infectious Diseases journal - CDC. [cited 2021 Jun 1]; Available from: https://wwwnc.cdc.gov/eid/article/27/1/20-3772_article</Citation><ArticleIdList><ArticleId IdType="pubmed">33058753</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibarrondo FJ, Fulcher JA, Goodman-Meza D, Elliott J, Hofmann C, Hausner MA, et al. Rapid decay of anti&#x2013;SARS-CoV-2 antibodies in persons with mild Covid-19. N Engl J Med. 2020;383(11):1085&#x2013;1087. doi: 10.1056/NEJMc2025179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2025179</ArticleId><ArticleId IdType="pmc">PMC7397184</ArticleId><ArticleId IdType="pubmed">32706954</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonn T, Corman VM, Johnsen M, Richter A, Rodionov RN, Drosten C, et al. Stability and neutralising capacity of SARS-CoV-2-specific antibodies in convalescent plasma. Lancet Microbe. 2020;1(2):e63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7279746</ArticleId><ArticleId IdType="pubmed">32835332</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallais F, Velay A, Nazon C, Wendling M-J, Partisani M, Sibilia J, et al. Intrafamilial exposure to SARS-CoV-2 associated with cellular immune response without seroconversion, France. Emerg Infect Dis. 2021;27(1):113&#x2013;121. doi: 10.3201/eid2701.203611.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2701.203611</ArticleId><ArticleId IdType="pmc">PMC7774579</ArticleId><ArticleId IdType="pubmed">33261718</ArticleId></ArticleIdList></Reference><Reference><Citation>Amanzio M, Howick J, Bartoli M, Cipriani GE, Kong J. How do nocebo phenomena provide a theoretical framework for the COVID-19 pandemic? Front Psychol. 2020;11:589884. doi: 10.3389/fpsyg.2020.589884.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2020.589884</ArticleId><ArticleId IdType="pmc">PMC7661580</ArticleId><ArticleId IdType="pubmed">33192929</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwong ASF, Pearson RM, Adams MJ, Northstone K, Tilling K, Smith D, et al. Mental health before and during COVID-19 in two longitudinal UK population cohorts. Br J Psychiatry. 2020;24:1&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7844173</ArticleId><ArticleId IdType="pubmed">33228822</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CH, Zhang E, Wong GTF, Hyun S, Hahm H &#x201c;Chris&#x201d;. Factors associated with depression, anxiety, and PTSD symptomatology during the COVID-19 pandemic: Clinical implications for U.S. young adult mental health. Psychiatry Res. 2020;290:113172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7263263</ArticleId><ArticleId IdType="pubmed">32512357</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosn J, Piroth L, Epaulard O, Turnier PL, Mentr&#xe9; F, Bachelet D, et al. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort. Clin Microbiol Infect [Internet]. 2021 May 10 [cited 2021 May 20];0(0). Available from: https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(21)00147-6/abstract</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8107834</ArticleId><ArticleId IdType="pubmed">34125067</ArticleId></ArticleIdList></Reference><Reference><Citation>Covid-19 will be followed by a deconditioning pandemic [Internet]. The BMJ. 2020 [cited 2021 Jan 3]. Available from: https://blogs.bmj.com/bmj/2020/06/15/covid-19-will-be-followed-by-a-deconditioning-pandemic/</Citation></Reference><Reference><Citation>Butler M, Pollak TA, Rooney AG, Michael BD, Nicholson TR. Neuropsychiatric complications of covid-19. BMJ. 2020 Oct 13;371:m3871.</Citation><ArticleIdList><ArticleId IdType="pubmed">33051183</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, et al. Autonomic dysfunction in &#x2018;long COVID&#x2019;: rationale, physiology and management strategies. Clin Med Lond Engl. 2021;21(1):e63&#x2013;e67. doi: 10.7861/clinmed.2020-0896.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, Dai Y, Huck JD, Jaycox JR, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;19:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xf8;ntvedt J&#xf8;rgensen M, Holter JC, Christensen EE, Schjalm C, Tonby K, Pischke SE, et al. Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19. Sci Rep. 2020;10(1):21697. doi: 10.1038/s41598-020-78710-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-78710-7</ArticleId><ArticleId IdType="pmc">PMC7729930</ArticleId><ArticleId IdType="pubmed">33303843</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamatovic SM, Shakui P, Keep RF, Moore BB, Kunkel SL, Van Rooijen N, et al. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab. 2005;25(5):593&#x2013;606. doi: 10.1038/sj.jcbfm.9600055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.jcbfm.9600055</ArticleId><ArticleId IdType="pubmed">15689955</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>